Q1 2024 · 13F-HR
Atle Fund Management ABholdings as filed
Filed 2024-04-25 · accession 0001381843-24-000004
$164.4M
Reported value
44
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 58933Y105 | MRK | MERCK & CO INC | $17.6M | 10.7% | 133,741 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $16.2M | 9.84% | 20,778 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $11.4M | 6.94% | 23,041 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $8.8M | 5.37% | 15,186 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $6.0M | 3.65% | 43,480 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $5.7M | 3.47% | 170,000 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $5.4M | 3.30% | 15,154 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $5.4M | 3.27% | 18,891 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $5.3M | 3.25% | 29,346 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $5.3M | 3.23% | 77,401 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $5.2M | 3.16% | 5,393 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $5.0M | 3.02% | 20,426 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $4.9M | 3.00% | 12,000 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $4.7M | 2.87% | 11,295 | Common | SOLE |
| 68404L201 | OPCH | OPTION CARE HEALTH INC | $4.5M | 2.71% | 132,895 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $3.8M | 2.33% | 7,400 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $3.8M | 2.32% | 52,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $3.6M | 2.22% | 26,283 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $3.1M | 1.88% | 123,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $3.1M | 1.87% | 27,500 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $3.0M | 1.81% | 252,307 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $3.0M | 1.80% | 138,836 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $2.8M | 1.68% | 63,791 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $2.7M | 1.62% | 40,899 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $2.6M | 1.60% | 38,050 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $2.5M | 1.55% | 10,058 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $2.4M | 1.44% | 24,775 | Common | SOLE |
| 82489T104 | SWAVUSD | SHOCKWAVE MED INC | $1.5M | 0.94% | 4,751 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $1.5M | 0.91% | 38,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $1.3M | 0.80% | 77,540 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $1.2M | 0.74% | 17,496 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $1.2M | 0.72% | 6,624 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $1.2M | 0.71% | 37,841 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $1.1M | 0.68% | 16,120 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $1.1M | 0.67% | 24,325 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $1.0M | 0.62% | 4,782 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $981,540 | 0.60% | 14,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $945,055 | 0.58% | 3,539 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $725,799 | 0.44% | 49,307 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $617,152 | 0.38% | 24,432 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $614,681 | 0.37% | 96,345 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $529,618 | 0.32% | 22,394 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $526,310 | 0.32% | 14,952 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $448,000 | 0.27% | 100,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.